Turner syndrome is a genetic condition that affects roughly 1 in every 2,000 to 4,000 females born worldwide. It occurs when one of the two X chromosomes is either missing entirely or partially altered, leading to a range of physical, developmental, and reproductive differences that can vary widely from person to person. Only females are affected, and while it cannot be cured, early diagnosis and ongoing care allow most girls and women with Turner syndrome to live full, healthy lives.
What Causes Turner Syndrome
Every cell in the human body typically carries two sex chromosomes. Females usually have two X chromosomes, and males have one X and one Y. In Turner syndrome, one of those X chromosomes is completely or partially absent. About half of all cases involve complete monosomy X, meaning every cell in the body contains just a single X chromosome instead of the usual pair.
The other half of cases fall into two categories. Some girls have a partially missing or rearranged second X chromosome rather than a fully absent one. Others have a mosaic pattern, where some cells carry the typical two X chromosomes and other cells have only one. Mosaic Turner syndrome tends to produce milder features and is often diagnosed later in life, sometimes not until adolescence or adulthood.
Turner syndrome is not inherited from a parent in the traditional sense. The chromosomal change happens randomly during early cell division, either before or shortly after conception. Nothing a parent did or didn’t do causes it, and there are no known risk factors that increase the chance of having a child with the condition.
When It Gets Diagnosed
Turner syndrome can be identified at very different ages depending on which features appear first. Some cases are caught before birth through prenatal ultrasound or genetic screening. In one study of patients, about 25% were diagnosed in infancy based on visible signs like swelling of the hands and feet (lymphedema) or a webbed appearance of the neck. Another 35% were identified during childhood, usually because a girl’s growth fell noticeably behind her peers.
The remaining 40% weren’t diagnosed until adolescence or adulthood, typically because of short stature combined with absent or delayed puberty, or because of difficulty conceiving. Girls with complete monosomy X tend to be diagnosed earlier, around age 7 on average, because their physical features are more pronounced. Those with mosaic forms are often diagnosed in their mid-teens or later, since their symptoms can be subtler.
The standard diagnostic test is a karyotype, which examines chromosomes from a blood sample. Standard karyotyping analyzes 20 to 30 cells, which means very low levels of mosaicism (under 10%) can be missed. When mosaicism is suspected, a more sensitive technique called FISH can scan a much larger number of cells, including cells from tissues other than blood, to catch cases that standard testing overlooks.
Physical Features and Growth
Short stature is the most universal feature of Turner syndrome, present in virtually all affected individuals. Without treatment, the average adult height is around 4 feet 8 inches. Other common physical traits include a short or broad neck, a wide chest with widely spaced nipples, and differences in nail shape. Some newborns have noticeable swelling in the hands and feet caused by fluid buildup in the lymphatic system.
Growth hormone therapy is the primary treatment for short stature. Most doctors begin treatment when a girl’s height drops well below the 5th percentile on a standard growth chart, which typically happens around age 9, though some specialists now start as early as age 2 before growth noticeably slows. The results vary, but treated girls generally gain between 5 and 8 additional centimeters (roughly 2 to 3 inches) of adult height compared to what they would have reached without treatment. In a Canadian clinical trial using a randomized control group, the average height gain from growth hormone was 7.2 centimeters. Some treatment protocols that combine growth hormone with other agents have achieved gains of up to 10 centimeters.
Heart and Kidney Health
About one-third of girls and women with Turner syndrome have a congenital heart difference. The two most common are a bicuspid aortic valve, found in roughly 16% of patients, and coarctation of the aorta (a narrowing of the body’s main artery), found in about 11%. A bicuspid aortic valve means the valve has two flaps instead of the usual three, which may function normally for years but can eventually lead to leaking or narrowing that requires monitoring or intervention. Coarctation can restrict blood flow and often needs surgical repair in childhood.
Because of these risks, cardiac imaging is recommended at the time of diagnosis regardless of age, with periodic follow-up throughout life. Aortic dilation, a gradual widening of the aorta that increases the risk of a dangerous tear, is another long-term concern that screening is designed to catch early.
Kidney differences, including a horseshoe-shaped kidney (where the two kidneys are fused at the bottom), also occur more frequently in Turner syndrome. These structural variations often cause no symptoms but can increase susceptibility to urinary tract infections, so an ultrasound of the kidneys is part of the initial workup after diagnosis.
Puberty and Fertility
The ovaries in most girls with Turner syndrome do not function typically. The ovaries often lose their egg supply prematurely, a process that can begin even before birth. As a result, most affected girls do not go through puberty on their own and will not have menstrual periods without hormone therapy. This is called primary ovarian insufficiency.
Estrogen replacement therapy is used to initiate puberty at the age it would normally occur, typically starting with low doses around age 11 or 12 and gradually increasing over several years to mimic the body’s natural progression. A progestin is added later to protect the uterine lining once estrogen doses reach a certain level. Current guidelines recommend continuing hormone therapy until around age 50 or 51, the average age of natural menopause, to protect bone density, heart health, and overall well-being.
Transdermal estrogen (patches or gels absorbed through the skin) is often preferred over oral pills because it avoids the liver’s “first-pass” processing, which may lower the risk of blood clots. It’s worth noting that combined hormonal contraceptives, like birth control pills, contain much higher and more potent hormone levels than what’s used for replacement and are not considered equivalent.
Spontaneous pregnancy is possible for a small percentage of women with Turner syndrome, particularly those with mosaic forms, but most will need assisted reproductive technology such as egg donation to conceive. Any pregnancy in a woman with Turner syndrome is considered high-risk because of the cardiovascular concerns, so thorough cardiac evaluation before conception is essential.
Thyroid and Hearing Concerns
Thyroid problems are strikingly common. Hypothyroidism, most often in a mild (subclinical) form, affects about 58% of women with Turner syndrome. The underlying cause is frequently autoimmune: roughly 42% of women with the condition test positive for thyroid antibodies, compared to about 20% in the general female population. Current clinical guidelines recommend screening thyroid function every one to two years starting at age 2 and continuing through adulthood.
Hearing issues are another area that requires consistent attention. Middle ear infections are more frequent and more persistent in girls with Turner syndrome, and chronic ear disease in childhood can lead to conductive hearing loss if not managed promptly. A different type of hearing loss, called sensorineural, can develop gradually and often worsens with age. Guidelines recommend hearing tests every two to three years during childhood and adolescence, shifting to every five years in adulthood. For adults who develop sensorineural hearing loss, monitoring for balance and vestibular problems is also recommended.
Cognitive and Social Profile
Overall intelligence in Turner syndrome is typically in the normal range, and verbal skills are often a real strength. Where differences emerge is in visual-spatial processing, the kind of thinking involved in reading maps, assembling puzzles, or judging distances. Executive function skills like planning, organizing, and shifting between tasks can also be more challenging.
Social cognition is another area where some girls with Turner syndrome face difficulties. Reading facial expressions, interpreting tone of voice, and navigating the unwritten rules of social interaction can be harder, a pattern that some researchers describe as consistent with a nonverbal learning profile. These challenges don’t reflect a lack of intelligence but can affect friendships and social confidence, especially during the school years. Neuropsychological testing can identify specific strengths and weaknesses early, making it possible to put targeted support in place before academic or social difficulties take root.
Long-Term Monitoring
Turner syndrome is a lifelong condition, and the care involved shifts as a girl grows into adulthood. In childhood, the focus is on growth, heart health, ear infections, and school support. In adolescence, puberty induction and psychosocial development take center stage. In adulthood, the priorities become cardiovascular surveillance, bone density, thyroid function, metabolic health, and fertility planning.
The 2023 international clinical guidelines, developed at the Aarhus International Turner Syndrome Meeting, emphasize that care should be coordinated across multiple specialties: cardiology, endocrinology, audiology, gynecology, and psychology, ideally through a multidisciplinary team familiar with the condition. With this kind of structured follow-up, most women with Turner syndrome lead independent, productive lives, and the outlook continues to improve as awareness and treatment options expand.